Search results

Please enter search term
Slaughter and May advised Ørsted on its proposed disposal of a 50% interest in the Borssele 1 & 2 Offshore Wind Farm Slaughter and May advised Ørsted on its proposed disposal of a 50% interest in the 752 MW Borssele 1 & 2 Offshore Wind Farm to Norges Bank Investment Management (NBIM). Slaughter and May advised DiaSorin S.p.A. on its USD 1.6bn financing package for its acquisition of Luminex Corporation Slaughter and May advised DiaSorin S.p.A., a global leader in the laboratory diagnostics market, specializing in immunodiagnostics and molecular diagnostics, on the USD 1.6bn bank financing package for its recently announced acquisition of Luminex Corpora... Slaughter and May advised MTR Corporation Limited on its issuance of CNY200 million 2.86% Fixed Rate Green Notes Slaughter and May, Hong Kong, advised MTR Corporation Limited on its issuance of CNY200 million 2.86% Fixed Rate Green Notes due 2022 (the Notes) under its US$7 billion Debt Issuance Programme. The Notes are listed on the Stock Exchange of Hong Kong Limit... Slaughter and May advised ASOS plc on the issuance of £500 million 0.75 per cent Guaranteed Senior Unsecured Convertible Bonds due 2026 Slaughter and May advised ASOS plc ("ASOS") on the issuance by ASOS' wholly owned subsidiary, Cornwall (Jersey) Limited, of £500 million 0.75 per cent guaranteed senior unsecured convertible bonds due 2026 ("the Bonds"), guaranteed by ASOS and ASOS.com Li... Slaughter and May is advising SEGRO European Logistics Partnership on its issue of €500m Guaranteed Notes due 2029 Slaughter and May is advising SEGRO European Logistics Partnership (“SELP”) on its issue (the “Issue”) of €500m 0.875 per cent. Guaranteed Notes due 2029 (the “Notes”). The Notes are being issued by SELP Finance S.à r.l. and guaranteed by SEGRO European L... Slaughter and May is advising Mediclinic International plc on Ramsay Health Care Limited's Recommended Cash Offer for Spire Healthcare Group plc Slaughter and May is advising Mediclinic International plc (“Mediclinic”) in relation to the recommended cash offer made by Ramsay Health Care Limited for the entire issued and to be issued ordinary share capital of Spire Healthcare Group plc (“Spire”). M... Slaughter and May advised Swire Properties Limited on the annual update of its US$4 billion Medium Term Note Programme Slaughter and May, Hong Kong, advised Swire Properties Limited on the annual update of the US$4 billion Medium Term Note Programme of its wholly-owned subsidiary, Swire Properties MTN Financing Limited. Slaughter and May advised Palamon Capital Partners on IDH Group transaction Slaughter and May advised Palamon Capital Partners (“Palamon”) on its partnership with the management team of IDH Group (“IDH” or the “Company”) to acquire the shareholding of The Carlyle Group (“Carlyle”) in the Company, as well as the shares of certain ... Slaughter and May advised Bloomsbury Publishing Plc on the acquisition of the issued share capital of Head of Zeus Limited Slaughter and May advised Bloomsbury Publishing Plc on the acquisition of the issued share capital of Head of Zeus Limited Slaughter and May is advising Standard Chartered on the launch of a Europe-based institutional digital asset trading venture Slaughter and May is advising Standard Chartered on the launch of a Europe-based institutional digital asset trading venture